The Lilly Diabetes Solution Center, a new patient-focused helpline with representatives who will identify personalized solutions to address insulin affordability, is now available to residents in the U.S. and all U.S. territories.
Beginning today, this suite of solutions will provide many options – some being offered for the first time – that can significantly lower and cap high monthly out-of-pocket costs for some people who use Lilly insulins such as Humalog® (insulin lispro) and Humulin® (insulin human injection). Dedicated representatives will review the personal circumstances and identify options for people who pay near the full list price, such as the uninsured and people in the deductible phase of their high-deductible insurance plans, as well as potential solutions for people with lower incomes.
“We don’t want anyone to have to pay full list price for their insulin, and many people who do will be able to pay significantly less by calling our helpline,” said Mike Mason, senior vice president, Connected Care and Insulins. “Our goal is to ensure that people paying high out-of-pocket costs for Lilly insulins are matched with the best solution available to reduce their financial burden and help ensure they receive the treatment they need.”
Help is available at the Lilly Diabetes Solution Center by dialing (833) 808-1234, where people can talk to representatives between the hours of 9 a.m. and 8 p.m. (ET) Monday through Friday. Services will be offered in English, Spanish and several other languages. The helpline offers a range of new solutions for people with the greatest need including point-of-sale savings, information on accessing insulin through free clinics, and support for immediate needs.
Savings will vary based upon the individual circumstances of each person who calls the helpline. For people who already have co-pay or co-insurance plans, or are enrolled in Medicare Part D, the cost at the pharmacy may not change. Based on estimates from market research data, more than 400,000 people living with diabetes in the U.S. and Puerto Rico could benefit from the new solution center. Lilly is promoting the helpline in a variety of ways including through paid advertising, social media and outreach to the diabetes community.